CCM
PGEN icon

Chiron Capital Management’s Precigen PGEN Stock Holding History

Chiron Capital Management’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$59K Buy
+10,350
New +$44.7K 0.05% 136
2025
Q3 		– Sell
-13,050
Closed -$18.5K – 134
2025
Q2 		$18.5K Hold
13,050
– – 0.02% 119
2025
Q1 		$19.4K Sell
13,050
-3,000
-19% -$4.72K 0.02% 114
2024
Q4 		$18K Sell
16,050
-1,500
-9% -$1.28K 0.02% 113
2024
Q3 		$16.6K Sell
17,550
-10,300
-37% -$13K 0.01% 118
2024
Q2 		$44K Sell
27,850
-100
-0.4% -$145 0.04% 113
2024
Q1 		$40.5K Buy
27,950
+3,900
+16% +$5.6K 0.04% 108
2023
Q4 		$32.2K Sell
24,050
-31,800
-57% -$37.4K 0.03% 116
2023
Q3 		$79.3K Buy
55,850
+9,944
+22% +$14.1K 0.07% 108
2023
Q2 		$52.8K Sell
45,906
-744
-2% -$878 0.04% 112
2023
Q1 		$49.4K Sell
46,650
-22,848
-33% -$32.9K 0.03% 122
2022
Q4 		$106K Buy
69,498
+23,222
+50% +$39.9K 0.07% 120
2022
Q3 		$98K Sell
46,276
-3,500
-7% -$7.38K 0.07% 116
2022
Q2 		$67K Sell
49,776
-21,771
-30% -$32.3K 0.04% 123
2022
Q1 		$151K Buy
71,547
+872
+1% +$2.12K 0.1% 116
2021
Q4 		$262K Sell
70,675
-4,566
-6% -$19.6K 0.19% 86
2021
Q3 		$375K Buy
75,241
+6,100
+9% +$35.1K 0.27% 69
2021
Q2 		$451K Buy
69,141
+4,700
+7% +$32.8K 0.38% 55
2021
Q1 		$444K Buy
64,441
+400
+0.6% +$3.38K 0.38% 47
2020
Q4 		$653K Buy
64,041
+18,700
+41% +$121K 0.54% 32
2020
Q3 		$159K Buy
+45,341
New +$215K 0.13% 79

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Chiron Capital Management's PGEN Position: Q2 2026 in Review

Chiron Capital Management opened a new position in Precigen (PGEN) in Q2 2026: 10,350 shares worth $59K. The stake represents 0.05% of the portfolio and ranks #136 among its holdings. This is a return to the name: Chiron Capital Management previously reported a position in PGEN as recently as Q2 2025.

Chiron Capital Management first reported a position in PGEN in Q3 2020 and has held it in 21 quarters since. The position peaked at $653K in Q4 2020. 210 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Chiron Capital Management held 10,350 shares of Precigen worth $59K as of Q2 2026.
  • Precigen was a new Chiron Capital Management position in Q2 2026.
  • Precigen made up 0.05% of Chiron Capital Management's portfolio in Q2 2026, its #136 holding.
  • Chiron Capital Management first reported a position in Precigen in Q3 2020 and has held it in 21 quarters since.
  • Chiron Capital Management's Precigen position peaked at $653K in Q4 2020.
  • 210 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Chiron Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.